期刊文献+

低分子肝素钠联合硫酸镁、拉贝洛尔治疗妊娠期高血压综合征49例疗效及安全性 被引量:5

Efficacy and Safety of Low Molecular Weight Heparin Sodium Combined with Magnesium Sulfate and Labetalol Hydrochloride in the Treatment of 49 Cases of Pregnancy Induced Hypertension Syndrome
下载PDF
导出
摘要 目的:探究低分子肝素钠联合硫酸镁、盐酸拉贝洛尔治疗妊娠期高血压综合征(PIH)的疗效以及安全性。方法:选取2019年5月至2020年5月期间南阳市中心医院收治的PIH患者98例,将受试者分为观察组、对照组,每组49例。对照组给予常规硫酸镁和盐酸拉贝洛尔治疗;观察组在对照组基础上联合低分子肝素钠治疗。治疗后比较两组患者收缩压(SBP)、舒张压(DBP)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)、D-二聚体(D-D2)以及24 h尿蛋白(24 h UP)、血尿素氮(BUN)、肌酐(Scr),并记录不良事件发生率。结果:两组患者血压均明显降低,且观察组降低更显著(P<0.05);24 h UP、BUN、Scr、FIB、D-D2相比治疗前亦降低;凝血功能指标PT、APTT均出现上升(P<0.05),观察组上升更显著(P<0.05);观察组不良事件发生率低于对照组(6.12% vs 24.49%,P<0.05);两组患者用药不良反应率差异无统计学意义(10.20% vs 14.29%,P>0.05)。结论:低分子肝素钠联合硫酸镁、盐酸拉贝洛尔治疗对缓解PIH临床症状、减轻肾功能损伤效果显著,且妊娠不良发生风险低,安全性高。 Objective:To investigate the efficacy and safety of low molecular weight heparin sodium combined with magnesium sulfate and labetalol hydrochloride in the treatment of pregnancy induced hypertension (PIH).Methods:98 patients with PIH treated in Nanyang Central Hospital from May 2019 to may 2020 were selected.The subjects were divided into observation group and control group,with 49 cases in each group.The control group was treated with conventional magnesium sulfate and labetalol hydrochloride.The observation group was treated with low molecular weight heparin sodium on the basis of the control group.After treatment,systolic blood pressure (SBP),diastolic blood pressure (DBP),prothrombin time (PT),activated partial thromboplastin time (APTT),fibrinogen(FIB),d-dimer(D-D2),24 h urinary protein (24 h UP),blood urea nitrogen (BUN) and creatinine (SCR) were compared between the two groups,and the incidence of adverse events was recorded.Results:The blood pressure of the two groups decreased significantly,the decrease in the observation group was more significant (P0.05).Conclusion:The combination of low molecular weight heparin sodium combined with magnesium sulfate and labetalol hydrochloride has a significant effect on alleviating the clinical symptoms of PIH and reducing the injury of renal function,with low risk of adverse pregnancy and high safety.
作者 霍飞霞 马静 吴玉 HUO Feixia;MA Jing;WU Yu(Nanyang Central Hospital,Henan Nanyang 473000,China)
机构地区 南阳市中心医院
出处 《药品评价》 CAS 2022年第12期760-762,共3页 Drug Evaluation
关键词 高血压 妊娠性 低分子肝素钠 盐酸拉贝洛尔 硫酸镁 Hypertension,pregnancy-induced Low molecular weight heparin sodium labetalol hydrochloride Magnesium sulfate
  • 相关文献

参考文献9

二级参考文献125

  • 1刘雁峰,贾淑英,佟锦香.腰-硬联合麻醉在无痛分娩中的应用效果及对产程的影响[J].宁夏医科大学学报,2013,35(6):714-716. 被引量:31
  • 2王德智,乔宠.妊娠期高血压疾病治疗现状与进展[J].中国实用妇科与产科杂志,2004,20(10):638-640. 被引量:26
  • 3American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy.Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy [J]. Obstet Gynecol, 2013, 122(5):1122-1131.
  • 4Magee LA, Pels A, Helewa M, et al.Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary[J]. J Obstet Gynaecol Can, 2014, 36(5):416-441.
  • 5Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance[J]. BMJ, 2010, 341 :c2207.
  • 6Lowe SA, Bowyer L, Lust K, et al. The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014[J]. Aust N Z J Obstet Gynaecol, 2015, 55(1):11-16.
  • 7Campos-Outcah D Sr. US Preventive Services Task Force: the gold standard of evidence-based prevention[J]. J Fam Pract, 2005, 54(6):517-519.
  • 8Magee LA, Hdewa M, Momquin JM, et al. Diagnosis, evaluation,and management of the hypertensive disorders of pregnancy[J]. J Obstet Gynaeeol Can, 2008, 30 (Suppl): S1-48.
  • 9Cote AM, Brown MA, Laln E, et al. Diagnostic accuracy of urinary spot protein: creatiniue ratio for proteinuria in hypertensive pregnant women: systematic review[J]. BMJ, 2008, 336(7651): 1003-1006.
  • 10Churchill D, Beevers GD, Meher S, et al, Diuretics for preventing pre-eclampsia[J]. Cochrane Database Syst Rev, 2007, 24 (1):CD004451.

共引文献1434

同被引文献47

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部